SOW
ABUS icon

State of Wyoming’s Arbutus Biopharma ABUS Stock Holding History

State of Wyoming’s Portfolio ABUS Stock Details ABUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-15,421
Closed -$74.2K – 1781
2025
Q4 		$74.2K Buy
+15,421
New +$69.3K 0.01% 1394
2024
Q4 		– Sell
-15,944
Closed -$61.4K – 1589
2024
Q3 		$61.4K Buy
+15,944
New +$61.2K 0.01% 1356
2023
Q2 		– Sell
-11,005
Closed -$33.3K – 1543
2023
Q1 		$33.3K Sell
11,005
-30,902
-74% -$87.2K 0.01% 1230
2022
Q4 		$97.6K Buy
41,907
+9,075
+28% +$21.7K 0.03% 777
2022
Q3 		$63K Buy
+32,832
New +$77.3K 0.03% 888

Other funds holding ABUS

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
WCM
Whitefort Capital Management New York $339M AUM 52.48% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

State of Wyoming's ABUS Position: Q1 2026 in Review

State of Wyoming sold out of Arbutus Biopharma (ABUS) in Q1 2026, closing a stake of 15,421 shares — an estimated $74.2K sold.

State of Wyoming first reported a position in ABUS in Q3 2022 and held it in 5 quarters. The position peaked at $97.6K in Q4 2022. 167 funds tracked by Wall St. Rank hold ABUS as of Q1 2026.

  • State of Wyoming reported no remaining Arbutus Biopharma position as of Q1 2026 after selling out during the quarter.
  • State of Wyoming sold 15,421 Arbutus Biopharma shares in Q1 2026, an estimated $74.2K.
  • State of Wyoming first reported a position in Arbutus Biopharma in Q3 2022 and held it in 5 quarters.
  • State of Wyoming's Arbutus Biopharma position peaked at $97.6K in Q4 2022.
  • 167 funds tracked by Wall St. Rank held Arbutus Biopharma as of Q1 2026.

Based on State of Wyoming's 13F filing for Q1 2026, filed 13 May 2026.